Skip to main content

Sodium Valproate: Research

Volume 506: debated on Friday 26 February 2010

To ask the Secretary of State for Health what research is being undertaken in the NHS on the use of Epilim (sodium valproate) for treatment in the NHS of diseases other than epilepsy. (318958)

The National Institute for Health Research (NIHR) is not at present funding any such research.

The NIHR health technology assessment programme commissions research where there is a gap in the knowledge the national health service has about healthcare treatments and tests. Suggestions for research topics can be made via the programme's open access form at: